Scilex Holding Co

Scilex Holding Company, which trades under the ticker VCKA, completed its de-SPAC business combination in November 2022 through a merger with Vickers Vantage Corp. I, a blank-check company sponsored by Vickers Capital Group that completed its IPO in 2021. The 8-K filed on November 17, 2022 reflects activity surrounding that transaction, which brought Scilex — a specialty pharmaceutical company focused on non-opioid pain management therapeutics — into the public markets. The combined entity operates in the healthcare and specialty pharma sector, targeting commercial-stage pain management products. Sign up for a SpacDesk account to access the full filing history, deal timeline, and analytics for VCKA and hundreds of other SPACs.